Like Encore Health Resources

closed 7/1/2014 via BusinessWire

Quintiles Transnational Corp., acquired Encore Health Resources

synopsis: Quintiles announced that it has completed the acquisition of Encore Health Resources, a leader in the health-information analytics and technology consulting services industry focused on healthcare providers.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. "
target: Encore Health Resources
Encore Health Resources provides world-class industry experts to the healthcare market who have specialized knowledge of the industry’s major clinical and business applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/31/2019 via Company Press Release

WELL Health Technologies Corp., will acquire KAI Innovations Inc.

synopsis: WELL Health Technologies Corp., a Vancouver-based company operating in healthcare, has agreed to acquire KAI Innovations. KAI, based in Ontario, has the third largest electronic medical record (EMR) user base in the province and is the largest provider of Open Source Clinical Application Resource EMR services to healthcare clinics in Canada.
buyer: WELL Health Technologies Corp. (TSXV:WELL:$6.80)
Canada-based WELL Health Technologies Corp. operates Primary Healthcare Facilities and an electronic medial record business that supports the digitization of clinics. WELL's objective is to empower doctors to provide the best advanced care possible leveraging the latest trends in digital health. "
target: KAI Innovations Inc.
Canada-based KAI Innovations has the third largest electronic medical record (EMR) user base in Ontario and is the largest provider of Open Source Clinical Application Resource (OSCAR) EMR services in Canada. KAI founded the OSCAR clinic at McMaster University Department of Family Medicine.
price ($mm)
$7.99
rev ($mm)
$3
EBITDA ($mm)
EV / rev
5.1x
EV / EBITDA
closed 10/1/2018 via GlobeNewswire

DAS Health, purchased Aprima EHR Book of Business from CriticalKey, LLC

synopsis: DAS Health, an industry leader in health IT and management, has acquired the Aprima® EHR book of business from CriticalKey, LLC, a consulting, software and management services company. Aprima offers a fully integrated, single application, single database EHR/practice management solution, as well as complete Revenue Cycle Management services.
buyer: DAS Health
DAS Health is a leading provider of Health IT and management solutions and a trusted consultant to independent physician groups, hospitals and healthcare systems across North America. Headquartered in Tampa, FL, DAS delivers superior health IT, medical billing and practice management solutions. "
seller: CriticalKey, LLC
The acquisition includes the Aprima® EHR book of business from CriticalKey, LLC, a consulting, software and management services company. Aprima offers a fully integrated, single application, single database EHR/practice management solution, as well as complete Revenue Cycle Management services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/4/2017 via Company Press Release

Atos SE, acquired The Breakaway Group

synopsis: Atos, a global leader in digital transformation, announced that it has closed the acquisition of Conduent’s Breakaway Group, a healthcare IT consulting company. The Breakaway Group helps healthcare professionals learn and adopt new EHR technologies.
buyer: Atos SE (ENXTPA:ATO:$14,259.69)
Atos SE is a leader in digital transformation with circa 100,000 employees in 72 countries. Serving a global client base, the Group is the European leader in Big Data, Cybersecurity and provides Cloud services, Infrastructure & Data Management, Business & platform solutions. "
target parent: Conduent Business Services
target: The Breakaway Group
The Breakaway Group is changing how healthcare professionals learn and adopt new EHR technologies. By helping end users adopt new software applications quickly and easily, providers have more time for patient care and healthcare executives see improved financial outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/6/2017 via BNC Analysis

Tech Mahindra Limited, will acquire The HCI Group

synopsis: Tech Mahindra has signed an agreement to acquire US-based healthcare IT consulting company CJS Solutions Group LLC, which conducts business as The HCI Group. The HCI Group works with tier-I healthcare service providers, primarily in the US and the UK, focusing on providing end-to-end implementation of Electronic Health Record (EHR) software.
buyer parent: Mahindra Group
buyer: Tech Mahindra Limited (NSEI:TECHM:$4,965.00)
Tech Mahindra represents the connected world, offering Consulting, Digital Transformation, Integrated Engineering, Business Services and Solutions, enabling Enterprises, Associates and the Society to Rise™. They have 112,800+ professionals across 90 countries, helping over 825 global customers. "
target: The HCI Group
Headquartered in Jacksonville, Florida, The HCI Group works with tier-I healthcare service providers, primarily in the US and the UK, focusing on providing end-to-end implementation of Electronic Health Record (EHR) and Electronic Medical Record (EMR) software, training and support services.
price ($mm)
$90*
rev ($mm)
$114
EBITDA ($mm)
EV / rev
0.9x
EV / EBITDA
closed 1/30/2017 via BNC Analysis

Concept Plus, LLC, acquired Thao Inc.

synopsis: Concept Plus, LLC, a professional services firm specializing in the comprehensive design, implementation, and maintenance of IT initiatives for the Federal Government has acquired health IT management firm Thao, Inc. (THAOINC). THAOINC provides health IT services and program management support exclusively to federal healthcare customers.
buyer: Concept Plus, LLC
Concept Plus, LLC is a professional services firm specializing in the comprehensive design, implementation, and maintenance of IT initiatives for the Federal Government. Concept Plus provides solutions in the areas of Oracle, Cloud Computing and Mobile technologies. "
target: Thao Inc.
THAOINC offers federal-specific expertise in EHR interoperability, identity management, and care delivery in organizations like the Department of Defense (DoD) and the Department of Veterans Affairs (DVA).
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/4/2016 via GlobeNewswire

Avaap, acquired Falcon Consulting Group

synopsis: Avaap announced it has acquired Falcon Consulting, LLC, a KLAS-leading Epic Systems implementation and optimization firm. Falcon offers consulting and evaluation related to Electronic Health Record systems, including revenue cycle optimization and clinical transformation, with offerings that netted a top-rated score in a 2016 KLAS research report.
buyer: Avaap
Avaap is one of the largest providers of IT services and technology solutions for organizations that rely on Infor and Epic enterprise software solutions for clinical, financial, supply chain and human resources management. "
target: Falcon Consulting Group
Falcon Consulting is a holistic healthcare provider consultancy that focuses on driving value in the Epic EHR space. It is dedicated to the improvement of clinical quality, financial sustainability, technology adoption and customer engagement.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2016 via GlobeNewswire

DAS Health, acquired Falcon Healthcare Systems

synopsis: DAS Health, the leading provider of patient-centric health IT and management services, has announced its fourth acquisition in eight months. The latest acquisition, Falcon Healthcare Systems, is a Las Vegas, Nevada-based provider of managed IT services, revenue cycle management, Practice Management, and EHR technologies.
buyer: DAS Health
DAS Health is a leading provider of Health IT and management solutions and a trusted consultant to many physician groups, hospitals and healthcare systems across North America. "
target: Falcon Healthcare Systems
Falcon Healthcare Systems is a veteran- and minority-owned company dedicated to delivering advanced corporate-grade IT solutions and services to a broad range of healthcare organizations, businesses, non-profit organizations, schools, and US military units.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2016 via BNC Analysis

KAI Innovations Inc., acquired Trimara Corporation

synopsis: KAI Innovations announced that it has acquired Trimara Corporation. The company is a medical technology company based in Ottawa that has a primary focus offering an Electronic Medical Record (EMR) solution to physicians in Ontario.
buyer: KAI Innovations Inc.
KAI Innovations has now become the leader in delivering McMaster University’s OSCAR Electronic Medical Record (EMR) software and IT Solutions to healthcare organizations in Ontario. "
target: Trimara Corporation
Trimara is an Ottawa-based technology solutions company specializing in electronic medical records systems, medical imaging systems and technology management for medical environments.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2016 via PR Web

HCTec Partners, acquired HIMS Consulting Group

synopsis: HCTec Partners, a healthcare IT and health information management staffing and consulting company, announced that it has acquired HIMS Consulting Group (“HIMS”). HIMS is a healthcare IT professional services firm with over 30 years of combined workforce management experience and proprietary development of professional consulting resources,
buyer: HCTec Partners
HCTec’s mission is to discover, develop, and deliver dynamic and innovative solutions to enhance healthcare services and patient care. Their services include staffing contract placements, temp-to-perm placements, and permanent placements, strategic services, managed services, and project work. "
target: HIMS Consulting Group
HIMS Consulting Group, Inc. is a healthcare IT professional services firm. HIMS' systematic approach delivers complete EMR solutions addressing the complex demands of IT resource planning ensuring successful project implementations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/23/2015 via BusinessWire

Accenture, will acquire Sagacious Consultants

synopsis: Accenture announced that it has finalized its agreement to acquire Sagacious Consultants, a leading electronic health record consulting practice, to help clients better manage healthcare quality, efficiency and costs. Sagacious will bring their specialized skills in implementation, systems integration, upgrades and optimization of EHR solutions.
buyer: Accenture (ACN:$43,968.43)
Accenture is a global management consulting, technology services and outsourcing company, with more than 336,000 people serving clients in more than 120 countries. "
target: Sagacious Consultants
Sagacious Consultants leverages its extensive Epic EHR and industry experience to offer innovative solutions to persistent problems within healthcare organizations. Their full suite of services is designed to help organizations thrive during and after the transition to Epic.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/29/2015 via BNC Analysis

Vertical Holdings, LLC, acquired SergeMD, Inc.

synopsis: In an effort to strengthen its medical portfolio, Vertical Holdings announced it has acquired Sergemd, a preeminent business and technology solutions provider for healthcare physician practices. Sergemd provides technical and medical consulting services to nearly 300 clients.
buyer: Vertical Holdings, LLC
Located in Charleston, SC with more than 1,000 clients in 21 states, Vertical Holdings, LLC has core business operations in health care, software development, technical training, B2B and B2C SaaS platforms, and medical consulting. "
target: SergeMD, Inc.
SergeMD is a healthcare focused business and technology solutions company formed in 2004. SergeMD currently provides EHR and IT services to over 75 physician practices and 200+ providers across the Mid-South and Southeast.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/26/2014 via BNC Analysis

8KMiles, acquired SERJ Solutions, Inc.

synopsis: 8KMiles, a global secure cloud solutions company, through its US subsidiary, announced the acquisition of SERJ Solutions, a provider of innovative Epic EHR consulting, custom application development, and support solutions for the healthcare market.
buyer: 8KMiles (BSE:512161:$56.81)
8KMiles is a global cloud computing company based in the U.S. The 8KMiles platform offers cloud and big data security services and solutions to better serve and meet the growing security and compliance needs of enterprises and government agencies. "
target: SERJ Solutions, Inc.
SERJ Solutions, Inc. provides Epic Electronic Health Record (EHR) consulting, custom application development, and support solutions for the healthcare market. The company is based in Orange, California.
price ($mm)
$2.59
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/16/2014 via BusinessWire

Cumberland Consulting Group, LLC, acquired Cipe Consulting Group, LLC

synopsis: Cumberland Consulting Group, a national healthcare technology implementation and project management firm, announced that it has acquired the assets of Cipe Consulting Group, LLC, a growing healthcare technology consulting firm specializing in electronic health records and revenue cycle system implementation and support.
buyer parent: Tailwind Capital Partners
buyer: Cumberland Consulting Group, LLC
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
target: Cipe Consulting Group, LLC
Cipe Consulting Group is a growing healthcare technology consulting firm specializing in electronic health records and revenue cycle system implementation and support, including workflow and business analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/5/2014 via BusinessWire

Huron Consulting Group Inc., acquired Vonlay, LLC

synopsis: Huron Consulting Group Inc., a leading provider of business consulting services, has completed its acquisition of the assets of Vonlay, LLC, a healthcare technology consulting firm, specializing in clinical information systems and electronic health records implementations, whereby Vonlay will be included in the Huron Healthcare segment.
buyer: Huron Consulting Group Inc. (HURN:$726.27)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: Vonlay, LLC
Vonlay, LLC is a healthcare technology consulting firm, specializing in clinical information systems and electronic health records implementations and optimizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/1/2014 via PR Newswire

Gordon Point Informatics Ltd. merged with Global Village Consulting Inc.,

synopsis: Global Village Consulting Inc., an informatics consulting and software development company, and Gordon Point Informatics Ltd., a health care information management consulting firm, are pleased to announce that they have merged effective January 1, 2014.
buyer: Global Village Consulting Inc.
Global Village Consulting Inc. is an informatics consulting and software development company. They help their clients understand their information technology needs, manage the change required, and deliver on solutions either directly or as the vendor management team. "
target: Gordon Point Informatics Ltd.
GPi is a health care information management consulting firm with market leading expertise and global experience in electronic health information standards, terminologies and health-system-wide integration strategies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/23/2013 via BNC Analysis

MedTech National, Inc., acquired Camber Health Partners

synopsis: MedTech National, Inc. announced its acquisition of the medical billing and practice management assets of Camber Health Partners Inc. Camber Health Partners delivers EHR technology and Revenue Cycle Management services to healthcare providers in an affordable model that supports the business needs of the independent practice.
buyer: MedTech National, Inc.
MedTech National, Inc. is a Health Care Information Technology (HCIT) company that provides an integrated health technology platform and revenue cycle management (RCM) services to medical practitioners. "
target: Camber Health Partners
Camber Health Partners delivers EHR technology and Revenue Cycle Management services to healthcare providers in an affordable model that supports the business needs of the independent practice.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/5/2013 via GlobeNewswire

Sterling Computers Corporation, acquired Wide River Technology Extension Center

synopsis: Sterling Computers Corporation, a leading provider of IT sales and services, announced that it has acquired Wide River Technology Extension Center (TEC), the health information technology consulting division of CIMRO of Nebraska. Wide River TEC offers technical assistance, guidance and information to support and accelerate healthcare providers.
buyer: Sterling Computers Corporation
Founded in 1996, Sterling Computers Corporation is an award-winning technology company focused on hardware, software, and technology services for Government, Healthcare, Education and Commercial customers. "
target parent: CIMRO of Nebraska
target: Wide River Technology Extension Center
Wide River TEC offers technical assistance, guidance and information on best practices to support and accelerate healthcare providers' efforts to become meaningful users of Electronic Health Records (EHRs), as well as the ability to exchange health information with other providers and agencies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/1/2012 via BusinessWire

McKesson Corporation, will acquire MED3000, Inc.

synopsis: McKesson and MED3OOO announced they have signed a definitive agreement under which McKesson will acquire MED3OOO, a national healthcare management and technology services company that helps improve outcomes for providers, health plans, employers, and the patients and employees they serve.
buyer: McKesson Corporation (MCK:$214,319.00)
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care. "
target parent: Mitsui & Co, Ltd
target: MED3000, Inc.
MED3OOO is a leading provider of healthcare management and technology services that improve outcomes for providers, health plans, and the patients and employees they serve. The company provides a broad array of proprietary solutions for physician groups, hospitals, health systems and others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2014 via BusinessWire

Quintiles Transnational Corp., acquired Encore Health Resources

synopsis: Quintiles announced that it has completed the acquisition of Encore Health Resources, a leader in the health-information analytics and technology consulting services industry focused on healthcare providers.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. "
target: Encore Health Resources
Encore Health Resources provides world-class industry experts to the healthcare market who have specialized knowledge of the industry’s major clinical and business applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2014 via BusinessWire

Quintiles Transnational Corp., acquired Encore Health Resources

synopsis: Quintiles announced that it has completed the acquisition of Encore Health Resources, a leader in the health-information analytics and technology consulting services industry focused on healthcare providers.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. "
target: Encore Health Resources
Encore Health Resources provides world-class industry experts to the healthcare market who have specialized knowledge of the industry’s major clinical and business applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2011 via BusinessWire

Quintiles Transnational Corp., acquired VCG

synopsis: Quintiles announced the acquisition of VCG & Associates and VCG BIO ("VCG"), based in Holliston, Mass., and Cave Creek, Ariz., respectively. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. "
target: VCG
VCG develops strategic healthcare marketing initiatives to address the challenges surrounding U.S. pharmaceutical market entry. It focuses on biopharma companies that need supplemental resources to maximize commercial opportunities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,474.88)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2009 via PR Newswire

ASG, Inc., acquired Ockham Development Group, Inc.

synopsis: ASG, Inc. a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.
buyer: ASG, Inc.
ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. "
target: Ockham Development Group, Inc.
Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina.
price ($mm)
rev ($mm)
$12
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/22/2009 via BusinessWire

PPD, Inc., acquired AbCRO, Inc.

synopsis: PPD, Inc. announced that it has completed the acquisition of AbC.R.O., Inc., a Bulgarian contract research organization. The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: AbCRO, Inc.
AbCRO provides a full range of Phase II-IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
price ($mm)
$36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2009 via PR Newswire

PharmaNet Development Group, Inc. merged with JLL Partners,

synopsis: JLL Partners, a leading private equity investment fund, and PharmaNet Development Group, Inc., a leading provider of clinical development services, announced the successful completion of the tender offer by JLL PharmaNet Holdings, LLC.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc. is a leader in outsourced clinical development that offers clinical-development solutions including early and late stage consulting services, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs.
price ($mm)[EV]
$101 [$186]
rev ($mm)
$451
EBITDA ($mm)
$26
EV / rev
0.4x
EV / EBITDA
7.1x
closed 1/27/2009 via BusinessWire

Altarum Institute, acquired KAI Research, Inc.

synopsis: Altarum Institute, a non-profit health systems research and consulting organization, has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI provides innovative, cost-effective and practical support to the pharmaceutical and biotech industry, academic institutions and the National Institutes of Health.
buyer: Altarum Institute
Altarum Institute is a nonprofit health systems research and consulting organization serving government and private-sector clients. "
target: KAI Research, Inc.
KAI Research provides innovative, cost-effective and practical support to the pharmaceutical and biotech industries. KAI currently supports pharmaco-vigilance activities for over 90 marketed drugs and is providing safety surveillance for dozens of ongoing clinical trials.
price ($mm)
$7.55
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
closed 3/13/2009 via BNC Analysis

Premier Research Group, acquired Pivotal Research Centers, LLC

synopsis: PHC, Inc. d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, announced Premier Research Arizona, LLC, a unit of Premier Research Group PLC, has signed a purchase agreement to acquire the assets of PHC's Pivotal Research Centers.
buyer: Premier Research Group
Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. "
target parent: Pioneer Behavioral Health
target: Pivotal Research Centers, LLC
Pivotal Research Centers, LLC provides clinical drug testing. It performs all phases of clinical research for Phase I to Phase IV drugs under development through two research sites. Pivotal was founded by Louis C. Kirby in 1993 and is based in Phoenix, Arizona.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2007 via Company Press Release

Chiltern International Inc., acquired Clinical Trial Management Services, Inc.

synopsis: Chiltern, a leading global clinical research organization (CRO), announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Clinical Trial Management Services, Inc.
Clinical Trial Management Services, Inc. provides clinical research services such as clinical trial management and monitoring services, such as project management, investigative site management and monitoring services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Encore Health Resources


read more

Encore Health Resources

KAI Innovations Inc.

CriticalKey, LLC

The Breakaway Group

Encore Health Resources

The HCI Group

Thao Inc.

Falcon Consulting Group

Falcon Healthcare Systems

Trimara Corporation

HIMS Consulting Group

Sagacious Consultants

SergeMD, Inc.

SERJ Solutions, Inc.

Cipe Consulting Group, LLC

Vonlay, LLC

Gordon Point Informatics Ltd.

Camber Health Partners

Wide River Technology Extension Center

MED3000, Inc.

read more

Encore Health Resources

Encore Health Resources

read more

Encore Health Resources

Quintiles Transnational Corp.

Encore Health Resources

VCG

Eidetics

read more

Invicro, LLC

Aptuit, Inc.

PAREXEL International Corporation

inVentiv Health, Inc.

Quintiles Transnational Corp.

Excel PharmaStudies Inc.

Encorium Group Inc.

Clinical Trials of the Americas, Inc.

Ockham Development Group, Inc.

AbCRO, Inc.

PharmaNet Development Group, Inc.

KAI Research, Inc.

Pivotal Research Centers, LLC

Clinical Trial Management Services, Inc.

Bio-Quant, Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

Geography
Matching Companies
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2017
rev ($mm)
$3,467.64
EBITDA ($mm)
$637.81
EBIT ($mm)
$406.82
Net Income ($mm)
$252.97
Employees
34651
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2009
rev ($mm)
$4,694.70
EBITDA ($mm)
$1,142.70
EBIT ($mm)
$949.40
Net Income ($mm)
$543.30
Employees
28000
  • drill down
  • watch